GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (NAS:ASND) » Definitions » Common Stock

ASND (Ascendis Pharma AS) Common Stock : $8.5 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma AS Common Stock?

Ascendis Pharma AS's quarterly common stock increased from Jun. 2024 ($8.4 Mil) to Sep. 2024 ($9.0 Mil) but then declined from Sep. 2024 ($9.0 Mil) to Dec. 2024 ($8.5 Mil).

Ascendis Pharma AS's annual common stock increased from Dec. 2022 ($8.1 Mil) to Dec. 2023 ($8.5 Mil) and increased from Dec. 2023 ($8.5 Mil) to Dec. 2024 ($8.5 Mil).

Ascendis Pharma AS Common Stock Historical Data

The historical data trend for Ascendis Pharma AS's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma AS Common Stock Chart

Ascendis Pharma AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.78 8.64 8.13 8.45 8.53

Ascendis Pharma AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.45 8.50 8.42 9.04 8.53

Ascendis Pharma AS Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Ascendis Pharma AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (NAS:ASND) » Definitions » Common Stock
Comparable Companies
TECH PCVX EXEL HALO JAZZ ROIV MDGL RVMD INCY SRPT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ASND:Mexico A71:Germany A1SN34:Brazil
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Website
https://www.ascendispharma.com
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.